Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
ALISO VIEJO, Calif., Nov. 22, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will participate in the Piper Jaffray 23rd Annual Health Care Conference.
- Piper Jaffray Health Care Conference
- Palace Hotel, New York, NY
- Wednesday November 30, 2011
- 2:00 p.m. ET
A live webcast and 30-day archive of this presentation will be available at http://www.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc.
©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.